Fundraising FoxElidah
1 known investors
Find your way into Elidah
Sign up to see every warm intro you have to Elidah
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Elidah team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Elidah develops an FDA-cleared external neuromuscular therapy platform for treating urinary incontinence in women and men, offered through direct-to-consumer and clinical care channels including telehealth and Medicare coverage.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AFeb 2024 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseDefense Health Program | Phase I | 2018 | $150K |
| National Science Foundation | Phase II | 2016 | $750K |
| National Science Foundation | Phase I | 2015 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Elidah do?
- Elidah develops an FDA-cleared external neuromuscular therapy platform for treating urinary incontinence in women and men, offered through direct-to-consumer and clinical care channels including telehealth and Medicare coverage.
- Who are Elidah's investors?
- Elidah's investors include Connecticut Innovations.